Key Points
- Director Maria Rivas bought 1,000 shares at $82.13 on Dec. 18 for $82,130, increasing her stake to 11,141 shares (a 9.86% rise) as disclosed in an SEC filing.
- Cooper beat quarterly estimates with $1.15 EPS vs. $1.11 expected and revenue of $1.07B vs. $1.06B, and set FY2026 guidance of 4.450–4.600 EPS (Q1 2026 guide 1.020–1.040).
- The board approved a $2.00 billion share repurchase program allowing buybacks of up to 15.4% of outstanding shares, a sign management may view the stock as undervalued.
The Cooper Companies, Inc. (NASDAQ:COO - Get Free Report) Director Maria Rivas purchased 1,000 shares of the stock in a transaction on Thursday, December 18th. The shares were purchased at an average price of $82.13 per share, for a total transaction of $82,130.00. Following the transaction, the director directly owned 11,141 shares of the company's stock, valued at approximately $915,010.33. This represents a 9.86% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this link.
Cooper Companies Price Performance
COO opened at $82.75 on Friday. The company has a current ratio of 1.89, a quick ratio of 1.13 and a debt-to-equity ratio of 0.30. The stock has a market capitalization of $16.22 billion, a P/E ratio of 44.02, a PEG ratio of 2.35 and a beta of 1.05. The stock has a 50-day moving average price of $74.70 and a 200-day moving average price of $71.99. The Cooper Companies, Inc. has a 12-month low of $61.78 and a 12-month high of $100.24.
Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Thursday, December 4th. The medical device company reported $1.15 earnings per share for the quarter, beating analysts' consensus estimates of $1.11 by $0.04. The company had revenue of $1.07 billion for the quarter, compared to analysts' expectations of $1.06 billion. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.Cooper Companies's revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period last year, the firm posted $1.04 EPS. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Equities analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.
Cooper Companies declared that its board has approved a stock repurchase program on Wednesday, September 17th that allows the company to buyback $2.00 billion in outstanding shares. This buyback authorization allows the medical device company to purchase up to 15.4% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's board believes its stock is undervalued.
Analyst Upgrades and Downgrades
Several equities analysts recently commented on COO shares. KeyCorp reaffirmed a "sector weight" rating on shares of Cooper Companies in a report on Friday, December 5th. Wells Fargo & Company boosted their price target on shares of Cooper Companies from $72.00 to $82.00 and gave the stock an "equal weight" rating in a research note on Friday, December 5th. Barclays reaffirmed an "overweight" rating and set a $91.00 price objective on shares of Cooper Companies in a research note on Monday, December 8th. Needham & Company LLC reiterated a "buy" rating and issued a $100.00 price objective (up previously from $94.00) on shares of Cooper Companies in a report on Friday, December 5th. Finally, Stifel Nicolaus set a $95.00 target price on Cooper Companies and gave the company a "buy" rating in a report on Friday, December 5th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $90.15.
View Our Latest Report on Cooper Companies
Institutional Investors Weigh In On Cooper Companies
A number of large investors have recently made changes to their positions in the business. Alecta Tjanstepension Omsesidigt grew its position in shares of Cooper Companies by 15.8% in the 3rd quarter. Alecta Tjanstepension Omsesidigt now owns 1,563,000 shares of the medical device company's stock worth $107,112,000 after buying an additional 213,500 shares during the last quarter. Allworth Financial LP lifted its stake in Cooper Companies by 23.9% in the third quarter. Allworth Financial LP now owns 1,188 shares of the medical device company's stock worth $81,000 after acquiring an additional 229 shares during the period. IFP Advisors Inc lifted its stake in Cooper Companies by 2,647.8% in the third quarter. IFP Advisors Inc now owns 632 shares of the medical device company's stock worth $43,000 after acquiring an additional 609 shares during the period. Swiss Life Asset Management Ltd boosted its holdings in Cooper Companies by 63.9% in the third quarter. Swiss Life Asset Management Ltd now owns 49,409 shares of the medical device company's stock valued at $3,387,000 after acquiring an additional 19,264 shares in the last quarter. Finally, CIBC Bancorp USA Inc. purchased a new position in Cooper Companies during the 3rd quarter valued at $1,887,000. 24.39% of the stock is currently owned by institutional investors.
About Cooper Companies
(
Get Free Report)
Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.
The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
